Top

Digestive Diseases and Sciences

Published in:

01-03-2012 | Original Article

Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction

Authors: Xiu-Feng Chen, Bo Zhang, Zhi-Xin Chen, Jian-Kun Hu, Bin Dai, Fang Wang, Hong-Xin Yang, Jia-Ping Chen

Published in: Digestive Diseases and Sciences | Issue 3/2012

Abstract

Background

The anastomosis of gastric remnant to esophagus after proximal gastrectomy is the traditional surgical treatment procedure for patients with types II and III adenocarcinoma of esophagogastric junction. However, the postoperative complications such as gastroesophageal reflux are frequent.

Aims

To assess the outcome of the intraperitoneal anastomosis of the reconstructed gastric tube to esophagus after proximal gastrectomy for types II and III adenocarcinoma of esophagogastric junction.

Methods

Seventy-six consecutive patients with preoperative diagnosis of type II or type III adenocarcinoma of esophagogastric junction were recruited. Forty-one patients had the traditional anastomosis of gastric remnant to esophagus and 35 patients underwent an anastomosis of esophagus to a gastric tube that was constructed from the gastric remnant after proximal gastrectomy.

Results

Twenty-three (56.1%) versus 12 (28.6%) patients (p = 0.016) complained various discomforts and/or were diagnosed with complications in the traditional group and gastric tube group, respectively, although there were no significant differences between the two groups in demographic data and pathological characteristics. Fourteen (34.1%) versus five (14.3%) patients (p = 0.046) complained of heartburn or acid regurgitation and nine (22.0%) versus two (5.7%) patients (p = 0.045) were confirmed reflux esophagitis in the traditional group and the gastric tube group, respectively.

Conclusions

The intraperitoneal anastomosis of the reconstructed gastric tube to esophagus demonstrates less complaints of gastroesophageal reflux and reflux esophagitis than the traditional anastomosis of gastric remnant to esophagus in the surgical treatment of types II and III adenocarcinoma of esophagogastric junction in 1-year follow-up.

Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053.PubMedCrossRef

Fan YJ, Song X, Li JL, et al. Esophageal and gastric cardia cancers on 4,238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J Surg. 2008;32:1980–1988.PubMedCrossRef

Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63–73.PubMedCrossRef

Johansson J, Djerf P, Oberg S, et al. Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J Surg. 2008;32:1013–1020.PubMedCrossRef

Barbour AP, Rizk NP, Gonen M, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14:306–316.PubMedCrossRef

Lehmann K, Schneider PM. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:65–72.PubMedCrossRef

An JY, Youn HG, Choi MG, Noh JH, Sohn TS, Kim S. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg. 2008;196:587–591.PubMedCrossRef

Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Brit J Surg. 2003;90:850–853.PubMedCrossRef

Shibuya S, Fukudo S, Shineha R, et al. High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy. World J Surg. 2003;27:580–583.PubMedCrossRef

10.

Shiraishi N, Hirose R, Morimoto A, Kawano K, Adachi Y, Kitano S. Gastric tube reconstruction prevented esophageal reflux after proximal gastrectomy. Gastric Cancer. 1998;1:78–79.PubMedCrossRef

11.

Washington K. 7th Edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–3079.PubMedCrossRef

12.

Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.PubMedCrossRef

13.

Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1001.PubMedCrossRef

14.

Carboni F, Lorusso R, Santoro R, et al. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection. Ann Surg Oncol. 2009;16:304–310.PubMedCrossRef

15.

Yoo CH, Sohn BH, Han WK, Pae WK. Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach. Cancer Res Treat. 2004;36:50–55.PubMedCrossRef

16.

Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127–130.PubMedCrossRef

17.

Shiraishi N, Adachi Y, Kitano S, Kakisako K, Inomata M, Yasuda K. Clinical outcome of proximal versus total gastrectomy for proximal gastric cancer. World J Surg. 2002;26:1150–1154.PubMedCrossRef

18.

Aihara R, Mochiki E, Ohno T, et al. Laparoscopy-assisted proximal gastrectomy with gastric tube reconstruction for early gastric cancer. Surg Endosc. 2010;24:2343–2348.PubMedCrossRef

19.

Sakamoto T, Fujimaki M, Tazawa K. Ileocolon interposition as a substitute stomach after total or proximal gastrectomy. Ann Surg. 1997;226:139–145.PubMedCrossRef

20.

Kim EM, Jeong HY, Lee ES, et al. Comparison between proximal gastrectomy and total gastrectomy in early gastric cancer. Korean J Gastroenterol/Taehan Sohwagi Hakhoe Chi. 2009;54:212–219.

21.

Kim HK, Choi YH, Shim JH, et al. Endoscopic evaluation of the quality of the anastomosis after esophagectomy with gastric tube reconstruction. World J Surg. 2008;32:2010–2014.PubMedCrossRef

22.

Ikeda Y, Niimi M, Kan S, Shatari T, Takami H, Kodaira S. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg. 2001;122:1101–1106.PubMedCrossRef

23.

Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept. 2008;149:15–25.PubMedCrossRef

24.

Kojima K, Yamada H, Inokuchi M, Kawano T, Sugihara K. Functional evaluation after vagus-nerve-sparing laparoscopically assisted distal gastrectomy. Surg Endosc. 2008;22:2003–2008.PubMedCrossRef

25.

Kolh P, Honore P, Degauque C, Gielen J, Gerard P, Jacquet N. Early stage results after oesophageal resection for malignancy—colon interposition vs. gastric pull-up. Eur J Cardio Thorac Surg. 2000;18:293–300.CrossRef

26.

Walther B, Johansson J, Johnsson F, Von Holstein CS, Zilling T. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg. 2003;238:803–812; discussion 812–804.

27.

Nagaya M, Kato J, Niimi N, Tanaka S, Iio K. Proposal of a novel method to evaluate anastomotic tension in esophageal atresia with a distal tracheoesophageal fistula. Pediatric Surg Int. 2005;21:780–785.CrossRef

28.

Yajima K, Kosugi S, Kanda T, Matsuki A, Hatakeyama K. Risk factors of reflux esophagitis in the cervical remnant following esophagectomy with gastric tube reconstruction. World J Surg. 2009;33:284–289.PubMedCrossRef

29.

Adachi Y, Inoue T, Hagino Y, Shiraishi N, Shimoda K, Kitano S. Surgical results of proximal gastrectomy for early-stage gastric cancer: jejunal interposition and gastric tube reconstruction. Gastric Cancer. 1999;2:40–45.PubMedCrossRef

30.

Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T. Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer. Eur J Surg. 2002;168:229–235.PubMedCrossRef

31.

Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg. 2006;243:204–211.PubMedCrossRef

32.

Lehnert T, Cardona S, Hinz U, et al. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival. Eur J Surg Oncol. 2009;35:986–993.PubMedCrossRef

33.

Lo CM, Fan ST, Liu CL, Lai EC, Wong J. Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg. 1998;133:156–161.PubMedCrossRef

34.

Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg. 2001;88:873–877.PubMedCrossRef

35.

Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (Clin Res Ed). 1985;290:1037–1039.CrossRef

36.

McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Brit J Surg. 1998;85:171–178.PubMedCrossRef

37.

Michiura T, Nakane Y, Kanbara T, et al. Assessment of the preserved function of the remnant stomach in pylorus-preserving gastrectomy by gastric emptying scintigraphy. World J Surg. 2006;30:1277–1283.PubMedCrossRef

38.

Kodama Y, Zhao CM, Kulseng B, Chen D. Eating behavior in rats subjected to vagotomy, sleeve gastrectomy, and duodenal switch. J Gastrointest Surg. 2010;14:1502–1510.PubMedCrossRef

39.

Tanizawa Y, Bando E, Kawamura T, et al. Influence of a positive proximal margin on oral intake in patients with palliative gastrectomy for far advanced gastric cancer. World J Surg. 2011;35:1030–1034.PubMedCrossRef

40.

Yuasa N, Miyake H, Yamada T, Ebata T, Nimura Y, Hattori T. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg. 2006;30:364–371.PubMedCrossRef

41.

Gaca JG, Petersen RP, Peterson BL, et al. Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. Ann Surg Oncol. 2006;13:340–346.PubMedCrossRef

Title: Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction
Authors: Xiu-Feng Chen
Bo Zhang
Zhi-Xin Chen
Jian-Kun Hu
Bin Dai
Fang Wang
Hong-Xin Yang
Jia-Ping Chen
Publication date: 01-03-2012
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 3/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-011-1920-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction

Abstract

Background

Aims

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Aims

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2012

Down-Regulation of CXCL12 by DNA Hypermethylation and Its Involvement in Gastric Cancer Metastatic Progression

Causes of Esophageal Food Bolus Impaction in the Pediatric Population

Tongue Hyperpigmentation Resulting from Peginterferon Alfa-2b and Ribavirin Treatment in a Patient with Chronic Hepatitis C

Effects of a Lactobacillus reuteri BR11 Mutant Deficient in the Cystine-Transport System in a Rat Model of Inflammatory Bowel Disease

Duodenal and Colonic Stent Placement with 0.025″ and 0.035″ Guidewires Is Equally Safe and Effective

Short and Long-Term Outcomes in Patients with Acute Liver Failure Due to Ischemic Hepatitis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page